Bone News and Research

RSS

Scientists are developing synthetic COVID-19 antibody to treat sick patients

A team of researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with GenScript, is developing a synthetic antibody to SARS-CoV-2, the virus that causes coronavirus disease (COVID-19). This antibody is intended to block the virus from entering human lung cells, and would be another potential treatment option for COVID-19.

24 Apr 2020

Researchers discover physiological mechanisms underlying pediatric B-ALL

B-cell acute lymphoblastic leukemia (B-ALL) is characterized by the accumulation of abnormal immature B-cell precursors in the bone marrow and is the most common pediatric cancer.

23 Apr 2020

A faster and easier treatment option to prevent blindness in preterm infants

Babies born prematurely who require treatment to prevent blindness from retinopathy of prematurity (ROP) could be treated with a dose of Avastin (bevacizumab) that is a fraction of the dose commonly used for ROP currently.

23 Apr 2020

New study may offer a breakthrough in treating telomere diseases

Capping decades of research, a new study may offer a breakthrough in treating dyskeratosis congenita and other so-called telomere diseases, in which cells age prematurely.

21 Apr 2020

COVID-19 and immunodeficiency

COVID-19 disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a highly infectious disease. As of today, over 170,000 people worldwide have succumbed to the infection. Reports have shown that some comorbidities and illnesses raise the risk of getting infected and also influence the severity of the disease. Having a compromised immune system can also drastically raise the risk of getting COVID-19.

21 Apr 2020

Racial and ethnic differences found in pain management of minority adolescents

Pain is one of the most common reasons for seeking emergency department care, yet is often poorly assessed and treated.

20 Apr 2020

New study raises red flags about strategy to block cancer drug resistance

Sooner or later, most cancer patients develop resistance to the very chemotherapy drugs designed to kill their cancer, forcing oncologists to seek alternatives.

17 Apr 2020

Greater occurrence of infections correlates with future cancer diagnosis

Patients experienced a greater occurrence of infections in the years preceding a cancer diagnosis.

17 Apr 2020

COVID-19 and type 2 diabetes have shared disease pathways, study finds

Individuals with diabetes are at increased risk for bacterial, parasitic and viral infections. New research published in Endocrine Reviews, a journal of the Endocrine Society, illuminates how intersections of the coronavirus infection (COVID-19) and type 2 diabetes may require new approaches in treatment for hospitalized patients.

15 Apr 2020

Stray dogs possible origin of COVID-19 pandemic

After tracing coronavirus signatures in different species, a new research article published in the journal Molecular Biology and Evolution shows that stray dogs (more specifically dog intestines) may have acted as the origin of current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.

14 Apr 2020

Researchers develop synthetic scaffolds for tendon and ligament regeneration

Australia's love of sport means it has one of the highest rates of knee anterior cruciate ligament (ACL) injury and reconstruction in the world.

14 Apr 2020

FDA approves first-ever treatment for patients with inoperable plexiform neurofibromas

The U.S. Food and Drug Administration has approved Koselugo (selumetinib) for use in patients with inoperable plexiform neurofibromas, a common manifestation in the disease neurofibromatosis type one (NF1).

13 Apr 2020

Lasers turn metal surfaces into bacteria killers

Purdue University researchers have discovered a laser treatment to texture metals that can potentially transform almost any metal surface into one that quickly eliminates any bacteria that come into contact with it.

12 Apr 2020

New €4.5 million collaborative project to develop cold plasma therapies for orthopedic infection

A University College Dublin researcher, Professor Paula Bourke, UCD School of Biosystems and Food Engineering, is principal investigator on a €4.5 million collaborative project to develop new therapies to treat an orthopedic infection with antibiotic-resistant microorganisms using cold plasma.

10 Apr 2020

$Study finds link between pre-school overweight and risk of bone fracture$

Study finds link between pre-school overweight and risk of bone fracture

Pre-school children who are overweight or obese have a higher risk of bone fractures during childhood than normal weight pre-schoolers, according to a study published in the Journal of Bone and Mineral Research.

9 Apr 2020

Novel technology reveals ear's inner secrets

What does it actually look like deep inside our ears? This has been very difficult to study as the inner ear is protected by the hardest bone in the body.

9 Apr 2020

Using computer software to optimize treatment for diabetic kidney diseases

Diabetic kidney diseases are the main cause of kidney failure in industrialized countries. An international, EU-funded R&D project - which is being headed by the Medical University of Innsbruck, and involves collaboration with the Medical University of Vienna and international partners - is being implemented with the aim of using computer software to provide personalized predictions of the disease's progression and bring about improvements in individuals' responses to treatment.

9 Apr 2020